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Background: Echinococcus granulosus is a major public health problem in lower middle-
income countries (LMIC). Children are commonly diagnosed with cysts in the lungs and/or the 
liver.  
Objectives: The purpose of this study was to describe a pediatric cohort diagnosed with 
pulmonary cystic echinococcus (CE) and treated with a combination of medical and surgical 
therapy. 
 
Methods: This was a retrospective study performed between July 2017 and December 2020 at 
Tygerberg Hospital, South Africa. Clinical, laboratory, radiological, medical, and surgery-related 
outcomes were reviewed. 
 
Results: The cohort consisted of 35 children, 17 (49%) were male, with a mean age of 9 ±5.4 
years and a mean weight of 20.3 ±8.3 kg. The most frequently encountered presenting symptom 
was cough (93%) followed by fever (70% ). Isolated pulmonary CE accounted for the majority 
of cases (74%) with  left lower lobe predominance. A significant proportion of the cohort 
exhibited chest computed tomography (CT) characteristics consistent with complicated 
pulmonary CE. Eighteen (58%) children had a positive indirect hemagglutination assay  test 
result. All children received medical treatment whilst 30 (86%) of children required surgery. 
Children with complicated pulmonary CE stayed a mean of 12.5 ±6.6 days, while those with 
simple cysts stayed 6.8 ±1.5 days. 
 
Conclusion: Isolated pulmonary CE is common in children, whereas extrapulmonary cysts are 
uncommon. Pulmonary CE is diagnosed using CXR, and CT imaging. IHA serology has limited 
diagnostic utility for pulmonary CE. Combined surgery and chemotherapy remain the gold 
standard for treating pulmonary CE. 
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Echinococcosis is a worldwide public health problem causing considerable pediatric morbidity 
and mortality in endemic areas[1]. There is clear evidence that echinococcus is endemic to sub-
Saharan Africa, however few studies outside of North Africa and the middle East have examined 
pediatric Cystic Echinococcal (CE) disease[2,3]. Despite a well-known lifecycle, the presentation, 
accuracy of diagnostic methods and treatment outcomes of pediatric echinococcal disease in sub-
Saharan and Southern Africa remains unclear.[2,3] 
 
The presentation of CE varies by age. Unlike adults, where hepatic involvement is common, 
pulmonary  CE is the dominant site in the pediatric population[4]. Pulmonary cyst/s are typically 
first seen on chest x-ray (CXR), either as an incidental finding or following respiratory 
symptoms after cyst rupture or secondary infection of the cyst[5].  Pulmonary cysts have a broad 
differential diagnosis in children and a definitive diagnosis relies on the combination of imaging, 
serology, and histology. In countries with high infectious burdens from diseases such as  Human 
Immune Deficiency Virus (HIV) and tuberculosis (TB)[2,3], the diagnosis is additionally 
challenging, as atypical infections are more common than in developed countries. Furthermore, 
the sensitivity of serology for CE is not well described and despite improved imaging modalities 
such as computer tomography (CT), the definitive diagnosis prior to surgery remains 
challenging. There are currently no available standard, highly sensitive, and specific test for 
detecting antibodies in CE [6].  
 
The incidence of complications in pediatric pulmonary CE, including mass effect, cyst rupture, 
chemical pneumonitis, anaphylaxis, and death, remains unclear[7]. Whilst a few published adult 
studies have evaluated cyst size, cyst rupture, and surgical management as prognostic factors for 
postoperative complications, there is a paucity of data on prognostic factors in the pediatric 
population.  There is also limited data to guide treatment type, duration of medical therapy and 







In this article we describe the presenting symptoms, radiological findings, treatment outcomes 
and complications of a pediatric cohort with pulmonary CE and treated with a combination of 




This retrospective, observational study was performed at Tygerberg Hospital (TCH). 
 
Site: TCH is a tertiary public healthcare facility serving a population of over 2 million people in 
the eastern metropolis and surrounding rural districts of the Western Cape, South Africa. 
 
Study population: The cohort included children aged 3-13-years, diagnosed with presumed 
pulmonary CE, admitted to the pediatric pulmonology unit at TCH between July 2017 and 
December 2020. 
 
Data were collected from the paediatric pulmonology and radiology databases, paediatric 
intensive care unit (PICU) admission records, cardiothoracic surgery register, and pathology 
records.  
Variables collected included sex, height, and age. Diagnostic data collected included results of 
CXR, CT, HIV status, complete blood counts, serum inflammatory markers, echinococcus 
serology, and histology.  
 
The children were classified according to their anthropometric measurements into normal growth 
or moderate acute malnutrition (MAM).  Children were classified  as normal if Weight-for-
length/height or BMI-for-age was ≥ -2 SD and ≤ 2 SD of the median, or mid-upper arm 
circumference ≥125 mm or as moderately malnourished if Weight-for-length/height or BMI-for-








For this study, CE diagnosis was based on the features as per the CT chest. Pulmonary cysts 
were classified as complicated and uncomplicated. Complicated pulmonary CE was defined as a 
cyst that was a completely or a contained rupture. Features of a contained ruptured cyst are air 
crescent, and/or inverse crescent and/or air bubble signs [Figure(s) 1-2]. Features of complete 
rupture are any of the following: cumbo, dry cyst, rising sun, waterlily, whirl, mass within the 
cavity signs. Uncomplicated pulmonary CE was defined as well-defined, homogeneous lesions 
with  low density and smooth, variable-thickness wall, irrespective of number or lobar 
location[14]. 
 
Histology/cytology was classified as either confirmed or uncertain echinococcus cyst. 
 
Standard treatment for all cases included the initiation of albendazole (20/mg/kg daily) therapy 
prior to surgical removal of the cyst by a cardiothoracic surgeon. Following surgery all patients 
were admitted to the PICU for monitoring and pain relief. Treatment with Albendazole was 
continued for a total of 3 months[15].  
 
Patients were followed up for a minimum of 3 months following surgery and were reviewed for 
cyst reoccurrence by CXR (pulmonary CE), liver ultrasonography (hepatic, splenic CE) and 
echocardiogram (cardiac CE), dependent on initial CE presentation. 
 
Statistical analysis:  
Descriptive data were reported as mean and standard deviation, if normally distributed, and as 
median with interquartile ranges, if not normally distributed. Chi-square and Students t-test were 
performed, as appropriate, to compare groups. A p-value of <0.05 was considered statistically 







Ethical permission for the study was obtained from the Stellenbosch University Committee for 
Human Research (HREC) Study number S19/09/193. A waiver of informed consent was applied 








The cohort consisted of 35 children. One patient had tuberculosis as an additional infection, 
detected by nucleic acid amplification (GeneXpert MTB/RIF). No differences existed in 
children’s demographics between complicated and uncomplicated cysts (Table 1). 
 
Table 1: Clinical characteristics of children with pulmonary echinococcal cyst (n=35) 
 
Presenting symptoms: Cough n=32 (91%) was the most common presenting symptom, followed 
by fever n=22 (63%), chest pain n=13 (37%), and shortness of breath n=9 (26%). There were no 
cases of haemoptysis or cyst fluid expectoration. No differences existed in children’s presenting 
symptoms between complicated and uncomplicated cysts (online supporting material Table 2). 
 
Haematology and serology. Eosinophilia was detected in only a few patients. The majority of 
children tested positive for antibodies. No differences existed between groups of children, except 
for CRP and positive serology (Table 1). 
 
Radiological findings: CXR was performed as the initial radiological investigation, after which 
all patients underwent chest CT and abdominal sonography (Table 2, online supporting material 
Table 1). 
Table 2: CT features of pulmonary echinococcal cysts in children at the time of presentation  
 
The majority of the cohort had a single lobe involvement on chest CT scan, and the majority of 
lesions were localised to a single lung (Table 2). The left lower lobe of the lung was most 
frequently affected n=16 (46%), followed by the left upper lobe n=10 (29%), right lower lobe 
n=9 (26%), right upper lobe n=6 (17%), right middle lobe n=5 (14%), and lingula n=2 (6%).  
Similar findings were apparent on CXR (online supporting material Table 1). CT chest, however, 








Complicated pulmonary CE was present in n=27 (77%) of cases (Table 2). Extra-pulmonary 
involvement was identified in 8 (23%) cases (Table 2).  
 
Microscopy and Histology: Only 30 children underwent surgery in our unit; the remaining 5 
children were either lost to follow-up or refused surgery. Histology of excised cysts or aspirated 
cyst content provided a definitive diagnosis in 22 (73%) of the cases, whilst 3 (10%) were 
uncertain and 5 (17%) specimens were not suitable for histological evaluation. In 8 (26%) of 
histologically confirmed CE cases, serology was negative.  
 
 
In uncomplicated cases the specimens consisted of the outer laminated, acellular, chitinous layer 
with either viable or non-viable germinal layer and brood capsules (Figure 1). In some cases, 
there might be a layer of acute inflammatory cells present on the outside of the capsule. In 
complicated cases, portions of the surrounding lobe were also resected and showed various 
stages of organizing inflammatory process (Figure 2). 
 
Treatment: All patients received medical treatment with oral albendazole 20 mg/day. Medication 
was initiated at least one week prior to surgery. Twenty-nine children underwent a single-stage 
cystectomy via a posterolateral thoracotomy and one child a median sternotomy, as deemed 
appropriate by the cardiothoracic surgeon. Patients with multiple extra-pulmonary organ 
involvement underwent a staged surgical procedure.  
 
Operative complications included air leak syndromes [pneumothorax n=2 (7%), surgical 
emphysema n=1 (3%)], haemothorax necessitating blood transfusion n=3 (10%), post-operative 
sepsis n=3 (10%), and anaphylaxis n=3 (10%). One patient required a repeat thoracotomy for a 







Follow-up and outcomes: The average length of stay was 9.0 ±5.4 days. Children with 
complicated CE stayed an average of 12.5 ±6.6 days, while those with simple cysts stayed an 
average of 6.8 ±1.5 days (p<0.001). Over the three-month post-operative follow-up period, no 







We present a cohort of children with pulmonary cystic echinococcal (CE) disease managed with 
medical and surgical intervention, with minimal complications and no reoccurrences at 3 months.  
 
The diagnosis of pulmonary CE remains challenging and relies on appropriate imaging (CXR 
and CT chest)[14–16], as serology and histology can often not establish a definitive diagnosis[17]. 
Pulmonary CE has a significant risk of acute complications pre and post-surgical 
intervention[10,18–20].  
 
This study indicates that the lung is the most common site of CE in children , similar to other 
pediatric data[4,5]. Pulmonary cysts grow slowly and are often asymptomatic until complications 
such as mass effect, rupture or secondary infection, occur[21]. Non-specific respiratory symptoms, 
including cough, fever, chest pain, and shortness of breath, were common in our patients, similar 
to previously published pediatric studies[10,15,22,23]. 
 
In the current study, no children presented with haemoptysis or cyst fluid expectoration, despite 
the high incidence of cyst rupture.  
 
The majority of primary infections present as a single cyst; however, multiple cysts and  
involvement of multiple organs have been reported[7,20,24]. This phenomenon was also observed 
in this cohort, where most children had a single pulmonary cyst. In the current study, the left 
lower lobe was most commonly affected, similar to previously published studies that indicated 
the lower lobes to be the most common site of pulmonary CE[14]. In contrast to published studies, 
only a few cases of giant hydatid cysts were present in this cohort[14,21] 
 
The diagnosis of pulmonary CE is made using a combination of imaging techniques, serological 
testing and histology of the excised cyst wall and cyst fluid content[9,15,25]. The radiological 






findings[14,15]. Cysts are classified into two broad categories: simple cysts (cysts with smooth 
walls) and complicated cysts (ruptured cysts or infected cysts)[14].  
 
Cumbo, Waterlily, and Whirl signs are all well-described radiological signs of ruptured cysts on 
CT Chest[14,15]. CXR are usually the initial radiological examination. However, compared to CT 
chest, CXR has limited sensitivity and, if available, CT chest is preferable[9,15,25]. While 
sonography is beneficial for identifying, staging, and monitoring hepatic cysts[25], its role in 
identifying pulmonary CE is unknown, and no studies, to date, have examined its use in pediatric 
pulmonary CE. 
 
Serological tests for CE lack sensitivity and cannot differentiate between Echinococcal exposure 
and active disease[17,25].  The current study’s findings indicate that IHA in pediatric pulmonary 
CE, demonstrated limited diagnostic utility. Newer tests, such as counter-immunelectrophoresis 
and enzyme-linked immunosorbant assay, have improved diagnostic sensitivity and should be 
used for both screening and diagnoses[17].  
Microscopic and histological examinations can aid in the diagnosis of CE[26]. Additionally, our 
data indicate that inflammatory markers are slightly elevated in complicated pulmonary CE 
compared to uncomplicated, an observation that will need to be confirmed in a larger data set. 
(Table 1) 
 
While surgical intervention is the preferred method of treating pulmonary CE, in some patients, 
pharmacotherapy may be beneficial[15,21]. There is conflicting evidence to guide treatment of 
pediatric complicated pulmonary CE[27] and no randomized trials comparing different treatment 
strategies have been conducted. The optimal timing of surgery is uncertain and requires 
additional investigation.  
 
In this cohort, surgery for pulmonary CE was associated with some postoperative complications 
but a had a generally positive outcome, similar to the majority of studies[10,22,28]. The majority of 
children in this study had complicated ruptured cysts prior to surgery. Cyst rupture is associated 






risk of surgical complication[14,15]. Additionally, patients with complicated pulmonary CE have a 
longer duration of hospitalization following surgical intervention. 
 
Children in this study recovered from pulmonary CE and were asymptomatic at the end of the 
follow up period.  
 
Several limitations apply to the current study. This was a single center, retrospective study which 
is unable to assess for local risk factors. Five patients were lost to follow-up, and some patients 
did not have serology performed, which may have skewed results. It will be beneficial to confirm 








Pulmonary CE causes considerable respiratory morbidity in children. Children rarely present 
prior to cyst rupture, complicating their care and potentially increasing the risk of further 
complications. The diagnosis of pulmonary CE relies on a combination of CXR, CT imaging and 
serology. However serological tests, such as IHA, have a limited diagnostic utility. While a 
combination of surgery and chemotherapy remains the gold standard for treating pulmonary CE, 
patients with complicated pulmonary CE require a longer hospital stay following surgical 
intervention. 
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List of tables 
 









Age, yrs., mean ±SD 7.0 2.8 7.0 ±2.8 7.0 ±2.9 1.00 
Males; n (%) 17 (49) 13(48) 4(50) 0.921 
Weight, kg, mean ±SD  20.3 ±8.3 20.0 ±8.7 20.5 ±6.3 0.881 
Height, cm, mean ±SD 118 ±17.8 113.0 ±18.4 120.0 ±13.2 0.325 
HIV status tested negative, n (%) 30(86)  23(85) 7(88) 0.833 
Nutritional status; (normal) n (%) 26(74) 20(74) 6(75) 0.955 
Nutritional status; (malnourished) n 
(%) 
          6(17) 8(30) 1(13) 0.343 
Laboratory Investigations 
White cell count (x109/L), mean ±SD 13.4 ±7.9 16.9 ±8.3 10.4 ±4.1 0.041 
Haemoglobin, g/dl, mean ±SD 11.1 ±1.58 10.7 ±1.7 11.5 ±0.6 0.204 
Eosinophils, (x 109/L), mean ±SD 0.36 ±0.90 0.4 ±1.0 0.36 ±0.4 0.913 
Albumin, g/L, mean ±SD 34 ±6.3 33.0 ±5.5 37.0 ±2.8 0.057 
CRP, mg/L, Median (IQR) 107 (7-237) 115 (52-268) 3 (2.5-125) 0.057 
Positive serology; n (%) a 18 (58) 16(59) 2(25) 0.095 













Table 2: CT features of pulmonary echinococcal cysts in children at the time of presentation  
Classification  Patients n (%) 
Uncomplicated 8(22) 
Complicated 27(77) 
Site  Patients n (%) 
Single lobe, n (%) 26 (74) 
Multiple lobe involvement, n (%) 9 (26) 
Unilateral, n (%) 28 (78) 
Bilateral, n (%) 7 (20) 
Giant cyst (>10cm), n (%) 6 (17) 
Lung and other organ involved liver, n (%) 8 (23) 
Lung & liver only  5/8 (63) 
Lung, liver & spleen 1/8 (13) 
Lung & cardiac only  1/8 (13) 
Lung & spleen only 1/8 (13) 
Features of complicated CE on CT Patients n (%) 
Parenchymal involvement (consolidation), n (%) 28 (80) 
Ruptured cyst, n (%) c 27 (77) 
Pleural effusion, n (%) 9 (26) 
Atelectasis, n (%) 6 (17) 







Supplemental Table 1: Anatomical location of hydatid cysts (CXR versus CT) 
Lobe Involvement  Frequency (n) CXR Frequency (n) CT 
Unilateral, (n) 28 28 
Bilateral involvement, (n) 5 7  
Right upper lobe, (n) 6  6  
Right middle lobe, (n) 3 5  
Right lower lobe, (n) 8 9  
Left upper lobe, (n) 8 10  
Lingula, (n) 1 2  








Supplemental Table 2: Clinical symptoms complicated versus non complicated   





Fever, n (%) 19 (70) 3(38) 0.091 
Cough, n (%) 25 (93) 7 (88) 0.652 
Chest pain, n (%) 9 (33) 4(50) 0.400 







Legends of figures  
 
 
Figure 1: Shows a viable organism from an uncomplicated echinococcus resection with the 
middle, acellular, chitinous layer (bottom right), an inner germinal matrix layer and multiple 
brood capsules that contain scolexes with hooklits. Haematoxylin and eosin stain, 10x. 
 
 
Figure 2: Lobectomy from a complicated echinococcosis case with a ruptured wall and necrotic 
fibrinopurulent material with fibrosis (indicative of outer layer) (upper right) with the lung 
parenchyma (bottom left) showing interstitial inflammation with fibrosis and foamy 









Figure 3: a-b Axial CT lung window images of various patients. (a) Imaging features of 
contained rupture. (b)The cyst, which resembled a water lily, was found peripherally and caused 








Figure 4: Axial CT showing a Complete cyst rupture  
Stellenbosch University https://scholar.sun.ac.za
